Taiwan FDA registration bbffe771c150f6a154cedd8a562bd0b9
"Neoscienceization" Myorest Human Immunodeficiency Virus Antibody Reagent
TW: “新科化” 妙芮絲人類免疫缺乏病毒抗體試劑
Taiwan·Risk Class 3·DIASORIN S.P.A. UK BRANCH·Registered Jul 16, 2012 – Aug 08, 2022CancelledRegistration details
- Analysis ID
- bbffe771c150f6a154cedd8a562bd0b9
- Customs Code
- DHA00602380302
Company information
- Manufacturer
- DIASORIN S.P.A. UK BRANCH
- Manufacturer Country
- United Kingdom
- Authorized Representative
- NEW SCIENTIFIC EQUIPMENT CO., LTD.
Product details
- Intended Use
- Enzyme immunoassay for statutory testing of human immunodeficiency virus type 1 (HIV-1, HIV-1O subtype) and type II (HIV-2) antibodies in human serum or plasma for screening.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
Dates and status
- Registration Date
- Jul 16, 2012
- Expiry Date
- Aug 08, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Neoscienceization" Myorest Human Immunodeficiency Virus Antibody Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bbffe771c150f6a154cedd8a562bd0b9 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices